- Home
- ELTX vs PMVP Comparison
ELTX vs PMVP Comparison
Compare ELTX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- PMVP
- Stock Information
- Founded
- ELTX 2011
- PMVP 2013
- Country
- ELTX United States
- PMVP United States
- Employees
- ELTX N/A
- PMVP N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ELTX Health Care
- PMVP Health Care
- Exchange
- ELTX Nasdaq
- PMVP Nasdaq
- Market Cap
- ELTX 158.5M
- PMVP 82.7M
- IPO Year
- ELTX N/A
- PMVP 2020
- Fundamental
- Price
- ELTX $9.29
- PMVP $1.41
- Analyst Decision
- ELTX Strong Buy
- PMVP Strong Buy
- Analyst Count
- ELTX 1
- PMVP 1
- Target Price
- ELTX $13.00
- PMVP $5.00
- AVG Volume (30 Days)
- ELTX 92.9K
- PMVP 778.7K
- Earning Date
- ELTX 11-07-2025
- PMVP 11-07-2025
- Dividend Yield
- ELTX N/A
- PMVP N/A
- EPS Growth
- ELTX N/A
- PMVP N/A
- EPS
- ELTX N/A
- PMVP N/A
- Revenue
- ELTX N/A
- PMVP N/A
- Revenue This Year
- ELTX N/A
- PMVP N/A
- Revenue Next Year
- ELTX N/A
- PMVP N/A
- P/E Ratio
- ELTX N/A
- PMVP N/A
- Revenue Growth
- ELTX N/A
- PMVP N/A
- 52 Week Low
- ELTX $4.23
- PMVP $0.81
- 52 Week High
- ELTX $12.62
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- ELTX 36.34
- PMVP 46.76
- Support Level
- ELTX $9.15
- PMVP $1.38
- Resistance Level
- ELTX $10.16
- PMVP $1.67
- Average True Range (ATR)
- ELTX 0.46
- PMVP 0.10
- MACD
- ELTX -0.06
- PMVP -0.01
- Stochastic Oscillator
- ELTX 8.86
- PMVP 29.74
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.